Here’s a money tip for your next coffee break: Ardelyx’s constipation drug is making waves, with Wall Street expecting it to hit $1 billion in sales by 2029—way ahead of schedule. That’s got the stock buzzing, up 3% premarket after a big upgrade. If you’re into health stocks, this could be one to watch. The real drama? A single pill is now the main event in Ardelyx’s growth story, and retail investors are calling it “pure gold.” #Business #Market #stocks